BiotechTube
Home/BOOST Pharma/Louise Himmelstrup
LH

Louise Himmelstrup

Chief Regulatory Officer

BOOST Pharma

Therapeutic Areas

Rare DiseaseGenetic DisordersOrthopedics

BOOST Pharma Pipeline

DrugIndicationPhase
BT-101 (BOOST Cells)Osteogenesis Imperfecta (moderate to severe, pediatric)Phase 3 Preparations

Leadership Team at BOOST Pharma

HS
Hans Schambye
Chief Executive Officer
EJ
Elaine Jones
Board Chair
DC
Dr. Cecilia Götherström
Chief Scientific Officer, Co-founder
View full BOOST Pharma profile